Atomoxetine in <font color="blue">autism_4</font> <font color="blue">spectrum_4</font> <font color="blue">disorder_4</font> <font color="blue">:_4</font> no effects on social functioning ; some beneficial effects on stereotyped behaviors , inappropriate speech , and fear of change . 
<br>
<br> UNLABELLED Abstract Objective : The objective of this study was to investigate the <font color="blue">short_1</font> <font color="blue">-_1</font> <font color="blue">term_1</font> <font color="blue">treatment_1</font> <font color="blue">effects_1</font> <font color="blue">of_1</font> <font color="blue">atomoxetine_1</font> <font color="blue">on_1</font> <font color="blue">autism_2</font> <font color="blue">spectrum_2</font> <font color="blue">disorder_2</font> <font color="blue">(_2</font> <font color="blue">ASD_2</font> <font color="blue">)_2</font> <font color="blue">symptoms_2</font> <font color="blue">in_2</font> <font color="blue">children_6</font> <font color="blue">and_6</font> <font color="blue">adolescents_6</font> <font color="blue">with_6</font> <font color="blue">both_6</font> <font color="blue">ASD_6</font> <font color="blue">and_6</font> <font color="blue">attention_6</font> <font color="blue">-_6</font> <font color="blue">deficit_6</font> <font color="blue">/_6</font> <font color="blue">hyperactivity_6</font> <font color="blue">disorder_6</font> <font color="blue">(_6</font> <font color="blue">ADHD_6</font> <font color="blue">)_6</font> <font color="blue">._6</font> <font color="blue">
<br>_1</font> METHODS <font color="blue">A_3</font> <font color="blue">total_3</font> <font color="blue">of_3</font> <font color="blue">97_7</font> <font color="blue">patients_7</font> <font color="blue">6_7</font> <font color="blue">-_7</font> <font color="blue">17_7</font> <font color="blue">years_7</font> <font color="blue">of_7</font> <font color="blue">age_7</font> <font color="blue">,_7</font> <font color="blue">with_7</font> <font color="blue">ASD_7</font> <font color="blue">and_7</font> <font color="blue">ADHD_7</font> <font color="blue">,_7</font> were treated with 1.2 â€‰ mg / kg / day of atomoxetine during an 8 week double - blind placebo - controlled period . Here , we investigated effects on two parent - based secondary outcome measures , the Aberrant Behavior Checklist ( ABC ) and the Children 's Social Behavior Questionnaire ( CSBQ ) . 
<br> RESULTS After 8 weeks of double - blind treatment , atomoxetine administration was associated with significant treatment effects on the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior , and on the CSBQ subscale Fear for Changes . 
<br> CONCLUSIONS Our study results indicate no beneficial effects of atomoxetine on social functioning . However , atomoxetine may ameliorate restricted and stereotyped behaviors and communication . This study has been registered in ClinicalTrials.gov ( www.clinicaltrials.gov ) under registration number NCT00380692 .